Completed EARLY_PHASE1 INTERVENTIONAL 4-arm NCT03019822

Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion Processing (LAM)

Sponsor: University Hospital, Basel, Switzerland

Conditions Healthy

Interventions Amphetamine LSD MDMA Placebo

Updated 8 times since 2017 Last updated: Oct 12, 2018 Started: Feb 1, 2017 Primary completion: Aug 11, 2018 Completion: Sep 4, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Healthy, this trial is completed. The trial is conducted by University Hospital, Basel, Switzerland and has accumulated 8 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Nov 2018 — Jan 2021 [monthly]

Completed EARLY_PHASE1

Status: Active Not Recruiting → Completed
Sep 2018 — Nov 2018 [monthly]

Active Not Recruiting EARLY_PHASE1

Status: Recruiting → Active Not Recruiting

▶ Show 3 earlier versions

Jun 2018 — Sep 2018 [monthly]

Recruiting EARLY_PHASE1
Jun 2017 — Jun 2018 [monthly]

Recruiting EARLY_PHASE1

Status: Not Yet Recruiting → Recruiting
Feb 2017 — Jun 2017 [monthly]

Not Yet Recruiting EARLY_PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Basel, Switzerland

Data source: University Hospital, Basel, Switzerland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Basel, Switzerland